Aging and Senolytics

The discussion dives into the complexities of using senolytics, particularly questioning the appropriateness of treatments like dysatnib for different age groups. There's a focus on the potential benefits of nutraceuticals for older individuals showing accelerated aging signs, emphasizing the need for personalized approaches. The conversation highlights the importance of understanding biological age and the impact of senescent cells on health, advocating for safety and individualized care in treatment decisions.